Shyamala Navada, MD, MSCR, Associate Professor, Hematology and Medical Oncology, @MountSinaiNYC @IcahnMountSinai provides perspective on how oral therapies will impact the treatment landscape of myeloid malignancies.
How Oral Therapies Will Impact the Treatment of Myeloid Malignancies
